mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort
Martin Filipits(University of Vienna), Peter Dubsky(Hirslanden Klinik St. Anna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Shaobo Zhao, Richard Greil(Paracelsus Medical University), Jodi Weidler, Sigurd Lax(Graz University Hospital), Margaretha Rudas(Comprehensive Cancer Center Vienna), Marija Balić(University of Pittsburgh), Michael Bates, Dominik Hlauschek(Austrian Breast & Colorectal Cancer Study Group), not provided Ping-Yen Wu, Christian F. Singer(Comprehensive Cancer Center Vienna)
Cited by 4
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k